Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
Vengoji R, Atri P, Macha MA, Seshacharyulu P, Perumal N, Mallya K, Liu Y, Smith LM, Rachagani S, Mahapatra S, Ponnusamy MP, Jain M, Batra SK, Shonka N.
Vengoji R, et al. Among authors: seshacharyulu p.
J Exp Clin Cancer Res. 2021 Oct 25;40(1):335. doi: 10.1186/s13046-021-02135-x.
J Exp Clin Cancer Res. 2021.
PMID: 34696786
Free PMC article.